NEW YORK – Early-stage women's health diagnostics firm PinkDx announced on Thursday that it has completed a second close of its $45 million Series A financing round.
The organization is leveraging its growing bank of whole-slide pathology images to create models that could form the backbone of cancer testing applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback